Cargando…
NPM2 in malignant peritoneal mesothelioma: from basic tumor biology to clinical medicine
BACKGROUND: This review systematically summarizes gene biology features and protein structure of nucleoplasmin2 (NPM2) and the relationship between NPM2 and malignant peritoneal mesothelioma (MPM), in order to explore the molecular pathological mechanism of MPM and explore new therapeutic targets. M...
Autores principales: | Wu, He-liang, Yang, Zhi-ran, Yan, Li-jun, Su, Yan-dong, Ma, Ru, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055711/ https://www.ncbi.nlm.nih.gov/pubmed/35490253 http://dx.doi.org/10.1186/s12957-022-02604-3 |
Ejemplares similares
-
Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases
por: Wu, He-liang, et al.
Publicado: (2022) -
Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study
por: Yang, Zhi-Ran, et al.
Publicado: (2022) -
Apatinib Mesylate Inhibits the Proliferation and Metastasis of Epithelioid Malignant Peritoneal Mesothelioma In Vitro and In Vivo
por: Yang, Zhi-Ran, et al.
Publicado: (2020) -
Establishment and histopathological study of patient-derived xenograft models and primary cell lines of epithelioid malignant peritoneal
mesothelioma
por: Yang, Zhi-Ran, et al.
Publicado: (2021) -
Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)